Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison

por Wang, Chen, Jing, Zhi-Cheng, Huang, Yi-Gao, Zhou, Da-Xin, Liu, Zhi-Hong, Meier, Christian, Nikkho, Sylvia, Curram, John, Zhang, Peng, He, Jian-Guo
Publicado 2016

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials...

por Wu, Wanlong, Jordan, Suzana, Graf, Nicole, de Oliveira Pena, Janethe, Curram, John, Allanore, Yannick, Matucci-Cerinic, Marco, Pope, Janet E, Denton, Christopher P, Khanna, Dinesh, Distler, Oliver
Publicado 2019

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

por Becker, Mike, Graf, Nicole, Sauter, Rafael, Allanore, Yannick, Curram, John, Denton, Christopher P, Khanna, Dinesh, Matucci-Cerinic, Marco, de Oliveira Pena, Janethe, Pope, Janet E, Distler, Oliver
Publicado 2019

Advancing clinical trial design in pulmonary hypertension

por Grieve, Andy P., Chow, Shien-Chung, Curram, John, Dawe, Stephen, Harnisch, Lutz O., Henig, Noreen R., Hung, Hsien Ming J., Ivy, D. Dunbar, Kawut, Steven M., Rahbar, Mohammad H., Xiao, Shen, Wilkins, Martin R.
Publicado 2013